Division of Cardiovascular Medicine, University of Manchester and Manchester Royal Infirmary, Manchester, UK.
Diabet Med. 2011 Oct;28(10):1261-7. doi: 10.1111/j.1464-5491.2011.03372.x.
We have assessed whether corneal confocal microscopy can be used to detect alterations in nerve morphology following an improvement in risk factors associated with diabetic neuropathy.
Twenty-five patients with diabetes with mild to moderate neuropathy and 18 control subjects underwent corneal confocal microscopy to quantify corneal nerve fibre (density, branch density, length and tortuosity) at baseline and after 24 months from first visit. This was not planned as an intervention trial and was simply an observational follow-up.
At baseline, nerve fibre density (18.8 ± 2.1 vs. 46.0 ± 3.8 number/mm(2), P = 0.001), nerve branch density (6.9 ± 1.5 vs. 35.6 ± 6.7 number/mm(2), P < 0.0001), nerve fibre length (8.3 ± 0.9 vs. 13.5 ± 0.8 mm/mm(2), P < 0.0001) and nerve fibre tortuosity (19.8 ± 1.6 vs. 22.7 ± 2.2, P < 0.05) were significantly lower in patients with diabetes than in control subjects. At follow-up, glycaemic control (HbA(1c) 64 ± 3 to 58 ± 2 mmol/mol, P = 0.08), total cholesterol (4.9 ± 0.2 to 4.2 ± 0.2 mmol/l, P = 0.01), systolic blood pressure (145.8 ± 4.9 to 135.9 ± 3.7 mmHg, P = 0.09) and diastolic blood pressure (77.8 ± 2.7 to 70.8 ± 2.5, P = 0.03) improved. Nerve fibre density (24.1 ± 2.0, P = 0.05), nerve branch density (11.1 ± 1.3, P < 0.01) and nerve fibre tortuosity (22.6 ± 1.5, P = 0.05) increased significantly, with no change in nerve fibre length (8.4 ± 0.5). Improvement in nerve fibre density correlated significantly with the improvement in HbA(1c) (r = -0.51, P = 0.008). Via four multifactorial regressions, this confirms the negative association between HbA(1c) and nerve fibre density (P = 0.02).
This study shows that corneal confocal microscopy may be employed in longitudinal studies to assess progression of human diabetic neuropathy and also supports the hypothesis that improvements in risk factors for diabetic neuropathy, in particular HbA(1c) , may lead to morphological repair of nerve fibres.
我们评估了角膜共聚焦显微镜是否可用于检测与糖尿病神经病变相关的危险因素改善后神经形态的变化。
25 例糖尿病伴轻度至中度神经病变患者和 18 例对照受试者在基线时和首次就诊后 24 个月时进行角膜共聚焦显微镜检查,以量化角膜神经纤维(密度、分支密度、长度和扭曲度)。这并不是一项计划中的干预试验,只是一项观察性随访。
基线时,糖尿病患者的神经纤维密度(18.8±2.1 比 46.0±3.8 个/毫米 2 ,P=0.001)、神经分支密度(6.9±1.5 比 35.6±6.7 个/毫米 2 ,P<0.0001)、神经纤维长度(8.3±0.9 比 13.5±0.8 毫米/毫米 2 ,P<0.0001)和神经纤维扭曲度(19.8±1.6 比 22.7±2.2 ,P<0.05)明显低于对照组。随访时,血糖控制(HbA 1c 从 64±3 降至 58±2mmol/mol,P=0.08)、总胆固醇(从 4.9±0.2 降至 4.2±0.2mmol/L,P=0.01)、收缩压(从 145.8±4.9 降至 135.9±3.7mmHg,P=0.09)和舒张压(从 77.8±2.7 降至 70.8±2.5,P=0.03)均有所改善。神经纤维密度(24.1±2.0,P=0.05)、神经分支密度(11.1±1.3,P<0.01)和神经纤维扭曲度(22.6±1.5,P=0.05)明显增加,而神经纤维长度无变化(8.4±0.5)。神经纤维密度的改善与 HbA 1c 的改善显著相关(r=-0.51,P=0.008)。通过四项多因素回归分析,这证实了 HbA 1c 与神经纤维密度之间的负相关关系(P=0.02)。
本研究表明,角膜共聚焦显微镜可用于纵向研究,以评估人类糖尿病神经病变的进展,也支持这样的假设,即改善糖尿病神经病变的危险因素,特别是 HbA 1c ,可能导致神经纤维的形态修复。